Capstone Investment Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,400
Closed -$49.7K 2113
2024
Q2
$49.7K Hold
2,400
﹤0.01% 1955
2024
Q1
$45.1K Sell
2,400
-3,900
-62% -$66.9K ﹤0.01% 2212
2023
Q4
$90.8K Buy
6,300
+1,900
+43% +$25.8K ﹤0.01% 1942
2023
Q3
$76.4K Buy
4,400
+500
+13% +$10.4K ﹤0.01% 1980
2023
Q2
$81.2K Hold
3,900
﹤0.01% 1720
2023
Q1
$91.7K Sell
3,900
-8,700
-69% -$234K ﹤0.01% 1379
2022
Q4
$352K Buy
12,600
+200
+2% +$5.11K ﹤0.01% 1193
2022
Q3
$290K Sell
12,400
-2,500
-17% -$75.5K ﹤0.01% 1397
2022
Q2
$503K Sell
14,900
-700
-4% -$24.5K ﹤0.01% 1229
2022
Q1
$545K Sell
15,600
-12,800
-45% -$438K ﹤0.01% 1466
2021
Q4
$865K Buy
28,400
+10,000
+54% +$326K ﹤0.01% 1349
2021
Q3
$603K Buy
+18,400
New +$589K ﹤0.01% 1522

Other funds holding OGN

Capstone Investment Advisors's OGN Position: Q4 2025 in Review

Capstone Investment Advisors sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 40,980 shares — an estimated $438K sold.

Capstone Investment Advisors first reported a position in OGN in Q3 2021 and held it in 12 quarters. The position peaked at $600K in Q3 2023. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Capstone Investment Advisors reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 40,980 Organon & Co shares in Q4 2025, an estimated $438K.
  • Capstone Investment Advisors first reported a position in Organon & Co in Q3 2021 and held it in 12 quarters.
  • Capstone Investment Advisors's Organon & Co position peaked at $600K in Q3 2023.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.